Measurement of Rho-associated kinase (ROCK) activity in humans: Validity of leukocyte p-MBS/t-MBS in comparison with vascular response to fasudil

Atherosclerosis

Volumn 214, Issue 1, 2011, Pages 117-121

  Hata, Takaki ^a   Goto, Chikara ^b   Soga, Junko ^a   Hidaka, Takayuki ^a   Fujii, Yuichi ^a   Idei, Naomi ^a   Fujimura, Noritaka ^a   Maruhashi, Tatsuya ^a   Mikami, Shinsuke ^a   Kihara, Yasuki ^a   Chayama, Kazuaki ^a   Noma, Kensuke ^a   Liao, James K ^c   Higashi, Yukihito ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Fasudil; Leukocyte; Rho associated kinase

Indexed keywords

FASUDIL; MYOSIN; MYOSIN BINDING SUBUNIT; MYOSIN LIGHT CHAIN PHOSPHATASE; RHO KINASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FOREARM BLOOD FLOW; HUMAN; LEUKOCYTE; MALE; PRIORITY JOURNAL; WESTERN BLOTTING;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ADULT; AGED; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; MYOSINS; PHOSPHORIC MONOESTER HYDROLASES; RHO-ASSOCIATED KINASES; VASODILATOR AGENTS;

EID: 78650832970     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.10.005     Document Type: Article

References (30)

1. Amano M., Chihara K., Kimura K., et al. Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 1997, 275:1308-1311.
2. Uehata M., Ishizaki T., Satoh H., et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997, 389:990-994.
3. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998, 279:509-514.
4. Takemoto M., Sun J., Hiroki J., Shimokawa H., Liao J.K. Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation 2002, 106:57-62.
5. Laufs U., Liao J.K. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 1998, 273:24266-24271.
6. Ming X.F., Viswambharan H., Barandier C., et al. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol 2002, 22:8467-8477.
7. Sawada N., Itoh H., Ueyama K., et al. Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries. Circulation 2000, 101:2030-2033.
8. Horwitz A.R., Parsons J.T. Cell migration-movin on. Science 1999, 286:1102-1103.
9. Mallat Z., Gojova A., Sauzeau V., et al. Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice. Circ Res 2003, 93:884-888.
10. Seasholtz T.M., Wessel J., Rao F., et al. Rho kinase polymorphism influences blood pressure and systemic vascular resistance in human twins: role of heredity. Hypertension 2006, 47:937-947.
11. Rikitake Y., Oyama N., Wang C.Y., et al. Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1 +/- haploinsufficient mice. Circulation 2005, 112:2959-2965.
12. Masumoto A., Mohri M., Shimokawa H., Urakami L., Usui M., Takeshita A. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 2002, 105:1545-1547.
13. Masumoto A., Hirooka Y., Shimokawa H., Hironaga K., Setoguchi S., Takeshita A. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 2001, 38:1307-1310.
14. Shimokawa H., Hiramori K., Iinuma H., et al. Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study. J Cardiovasc Pharmacol 2002, 40:751-761.
15. Noma K., Higashi Y., Jitsuiki D., et al. Smoking activates rho-kinase in smooth muscle cells of forearm vasculature in humans. Hypertension 2003, 41:1102-1105.
16. Noma K., Goto C., Jitsuiki D., et al. Smoking, endothelial function, and Rho-kinase in humans. Arterioscler Thromb Vasc Biol 2005, 25:2630-2635.
17. Ishikura K., Yamada N., Ito M., et al. Beneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertension. Circ J 2006, 70:174-178.
18. Kureishi Y., Kobayashi S., Amano M., et al. Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem 1997, 272:12257-12260.
19. Somlyo A.P., Somlyo A.V. Signal transduction and regulation in smooth muscle. Nature 1994, 372:231-236.
20. Higashi Y., Sasaki S., Kurisu S., et al. Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: role of endothelium-derived nitric oxide. Circulation 1999, 100:1194-1202.
21. Higashi Y., Sasaki S., Nakagawa K., Matsuura H., Oshima T., Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002, 346:1954-1962.
22. Noma K., Goto C., Nishioka K., et al. Roles of rho-associated kinase and oxidative stress in the pathogenesis of aortic stiffness. J Am Coll Cardiol 2007, 49:698-705.
23. Kishi T., Hirooka Y., Masumoto A., et al. Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure. Circulation 2005, 111:2741-2747.
24. Feske S.K., Sorond F.A., Henderson G.V., et al. Increased leukocyte ROCK activity in patients after acute ischemic stroke. Brain Res 2009, 1257:89-93.
25. Rawlings R., Nohria A., Liu P.Y., et al. Comparison of effects of rosuvastatin (10mg) versus atorvastatin (40mg) on rho kinase activity in caucasian men with a previous atherosclerotic event. Am J Cardiol 2009, 103:437-441.
26. Nohria A., Prsic A., Liu P.Y., et al. Statins inhibit Rho kinase activity in patients with atherosclerosis. Atherosclerosis 2009, 205:517-521.
27. Liu P.Y., Liu Y.W., Lin L.J., Chen J.H., Liao J.K. Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation 2009, 119:131-138.
28. Bao W., Hu E., Tao L., et al. Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury. Cardiovasc Res 2004, 61:548-558.
29. Wolfrum S., Dendorfer A., Rikitake Y., et al. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol 2004, 24:1842-1847.
30. Nohria A., Grunert M.E., Rikitake Y., et al. Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease. Circ Res 2006, 99:1426-1432.